Karnataka High Court Issues Notice on Challenge to Hospital Drug-Price Disclosure Mandate

The Karnataka High Court has issued notices to the State government and central authorities on a petition challenging a circular that requires private hospitals and nursing homes to disclose purchase prices of drugs and devices, bringing questions of transparency and drug price control before a single-judge Bench. Justice C.M. Poonacha directed notice to the State government, the Commissioner of Food Safety and Drugs Administration and the Union Ministry of Health and Family Welfare. Dr. Shobha Prakash and others, representing private healthcare associations, filed the petition. The Bench posted the matter to October 30.

According to the petitioners, the October 1 circular directs private hospitals and nursing homes to disclose the landing base price of medicines, medical equipment and consumables from November 1. They have asked the court whether such a mandate can be imposed by circular and whether the authorities cited have the power to issue it. Those questions remain undecided. Notice, for now, only calls for answers before the next date.

Hospital bills are at the centre of the dispute. Private hospital invoices often list medicines, implants, stents, syringes, gloves and catheters at rates above the maximum retail price printed on the pack or above outside pharmacy rates. The circular answers that grievance by requiring hospitals to reveal the landing base price, the price the hospital itself paid before handling, storage or service charges are added. The petition does not deny that billing complaints exist. It asks whether forced disclosure in this form is allowed under current law.

Circular directs disclosure from November 1

The circular, as described to the court, would operate from November 1. The material before the court does not spell out how disclosure must happen, whether on bills, on display boards, in registers open to inspection, or online. That detail will matter. A direction to print two prices on every bill is a different task from a direction to keep procurement records ready for inspection. Counsel for the petitioners are expected to place the full text of the October 1 circular before the court on the next date, with any follow-up instructions for implementation.

A November 1 start leaves a short window to change billing software, train front-office and pharmacy staff, and align purchase records across suppliers. Hospitals buy the same medicine or device from different distributors at different times, and rates shift by batch, quantity and supply contract. The petitioners contend a single landing base price will be hard to state fairly on a patient bill without further explanation. The State is likely to say that variation is the reason disclosure is needed, so patients can see what the hospital paid and what was added.

Hospital circular tests drug price control limits

The legal fight, on the material available, turns on authority and burden. The petitioners contend the mandate imposes an onerous pricing and compliance burden beyond statutory authority. Even if transparent billing is accepted as a goal, the Commissioner of Food Safety and Drugs Administration cannot create a fresh disclosure duty for hospitals without a clear provision in the governing statute, rules or drug pricing orders. The Union Ministry of Health and Family Welfare has been made a respondent, pointing to the shared role of the Centre in regulation of drugs, medical devices and clinical establishments.

On that basis the court will have to test which law, if any, supports the October 1 circular. Issues of this kind often turn on whether the circular is an executive instruction or a regulatory order, whether it changes the rights and duties of private hospitals, and whether those affected were heard before it was issued. The answers will depend on the text of the circular and the provisions cited by the State. No finding has been recorded so far. The Bench has confined itself to issuing notice and fixing a returnable date.

Compliance burden cited by private hospitals

The petition covers a wide field, from large corporate hospitals in Bengaluru to small nursing homes in district towns. Large hospitals run centralised pharmacies with electronic records that could, with changes, capture purchase prices. Smaller nursing homes buy in small lots from local stockists and keep manual bills. A uniform disclosure rule would land differently on the two. The petitioners are expected to argue that software cost, staff time and record-keeping will weigh on smaller units, with no clarity yet on how disclosure will be checked.

Behind the case lies public pressure for clearer bills. Patients rarely see procurement invoices and often learn the cost of medicines and consumables only at discharge. Price comparison is now routine, and searches can run to specifics such as birth control pills philippines mercury drug price when buyers check the same product across markets. The State is likely to cite that expectation to defend the circular as a help for informed choice and questioning of margins. The petitioners are likely to answer that transparency needs a law which sets out duties, safeguards and penalties with precision.